AI assistant
ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2025
Sep 13, 2025
32464_dirs_2025-09-12_e690cfe2-2465-42a3-a0ca-72b7c00583e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2025-09-11
Reporting Person: MISSLING CHRISTOPHER U (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-09-11 | Common Stock | M | 187500 | $5.04 | Acquired | 1655213 | Direct |
| 2025-09-11 | Common Stock | F | 145048 | $9.58 | Disposed | 1510165 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-09-11 | Stock Option (Right to Buy) | $5.04 | M | 187500 | Disposed | 2025-09-18 | Common Stock (187500) | Direct |
Footnotes
F1: Represents a "net exercise" of outstanding stock options, which options were scheduled to expire on September 18, 2025. The reporting person received 42,452 shares of common stock on net exercise of an option to purchase 187,500 shares of common stock. The Company withheld 145,048 shares of common stock underlying the option as consideration for the exercise price and tax withholdings, using the closing price on September 11, 2025 of $9.58, pursuant to the terms of the Company's 2015 Stock Option Plan.